Related Experiment Video
Updated: Jul 28, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
National Oncology Forum: perspectives for the year 2000
1Yale Cancer Center and the Yale University School of Medicine, New Haven, Connecticut 06519, USA.
Cancer Journal (Sudbury, Mass.)
|August 16, 2001
Summary
Gene expression profiling using DNA microarrays reveals distinct patient subgroups in diffuse large B cell lymphoma (DLBCL). This cancer research identifies patterns linked to chemotherapy response, offering new diagnostic and therapeutic avenues.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Long-term outcomes for diffuse large B cell lymphoma (DLBCL) have not improved since 1975.
- Gene expression patterns in cancer cells can influence treatment response.
Purpose of the Study:
- To investigate the utility of DNA microarray technology in understanding DLBCL.
- To identify gene expression patterns correlating with chemotherapy response in DLBCL patients.
Main Methods:
- DNA microarray technology was employed to analyze gene expression profiles in DLBCL patient samples.
- cDNA and oligonucleotide microarrays were utilized for gene expression profiling.
- Tissue microarrays were used to analyze gene amplification and protein expression in various cancers.
Main Results:
- Patients with DLBCL whose tumors showed gene expression patterns similar to germinal center lymphocytes responded better to chemotherapy.
- Patients with gene expression patterns resembling activated lymphocytes had a less favorable response to chemotherapy.
- Microarray technology demonstrated applications in profiling gene expression for diagnosis, prognosis, and identifying drug resistance markers.
Conclusions:
- Gene expression profiling via DNA microarrays can differentiate DLBCL subtypes with distinct clinical outcomes.
- This technology aids in predicting chemotherapy response and identifying potential therapeutic targets.
- Combining DNA and tissue microarrays offers a powerful approach for comprehensive cancer research.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:23International Nursing Organizations I
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...